NCT07417462
Assessment of a Multimodal Analgesia for Enhanced Recovery After Cardiac Surgery
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 15 words
- Trial completed
- Secondary endpoints: details revised at 5 of 8 entries
- Site details revised
- Minor Primary completion pushed from Jun 1, 2026 to Aug 1, 2026
- Study completion pushed from Jun 1, 2026 to Sep 1, 2026
- Study title shortened, about 4 words
- Minor Primary completion date: Jun 1, 2026 to Aug 1, 2026
- Study completion date: Jun 1, 2026 to Sep 1, 2026
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Feb 20, 2026 to Feb 18, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (8)
Show 3 moreShow less
Arms and interventions
Patients will receive pecto-intercostal fascial block intraoperatively (20 ml of bupivacaine 0.25% + 1 ml dexamethasone 8 mg).
Patients will receive transversus thoracic muscle plane block was performed intraoperatively (20 ml of bupivacaine 0.25% + 1 ml dexamethasone 8 mg).
Patients will receive bilateral superficial needle puncture at a location like transversus thoracic muscle plane block without any solution injected. Only 25 saline will be injected superficially.
Other: Pecto-intercostal fascial block, Transversus thoracic muscle plane block, Sham (No Treatment)
Sites
1 site in 1 country
- Assiut UniversityAsyut, Asyut Governorate, Egypt